This is a preview of subscription content, log in via an institution to check access.
References
De Keyser J, Van de Velde V, Schellens RLLA, et al. Safety and pharmacokinetics of the neuroprotective drug lubeluzole in patients with ischemic stroke. Clin Ther 1997 Nov–Dec; 19: 1340–51
Hantson L, Wessel T, Tritsmans L. Cardiovascular safety of lubeluzole in ischemic stroke patients. Int Pharm Abstr 1996 Nov 15; 33: 2271
Grotta J, US and Canadian Lubeluzole Stroke Study Group. Lubeluzole treatment of acute ischemic stroke. Stroke 1997 Dec; 28: 2338–46
Diener HC, European and Australian Lubeluzole Ischaemic Stroke Study Group. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. Cerebrovasc Dis 1998 May–Jun; 8: 172–81
Diener H-C, Hacke W, Hennerici M, et al. The effects of lubeluzole in the acute treatment of ischemic stroke; results of a phase-2 trial. Stroke 1995 Jan; 26: 185
Carlson R. Rough road to development for neuroprotectants in acute stroke. Inpharma 1996 Mar 9; 1027: 9–10
Rights and permissions
About this article
Cite this article
Lubeluzole. Drugs R&D 1, 29–31 (1999). https://doi.org/10.2165/00126839-199901010-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-199901010-00011